Symyoo provides the consulting services for the K-Bio companies wishing to enter the US or global market and to run multinational, multisite clinical trials.
Symyoo’s global consulting team has broad experience and expert knowledge in various therapeutic areas and trials conducted under FDA Investigational New Drug (IND) and Investigational Device Exemption (IDE) applications with average 20+ years experience at global scale.
The global consulting team will guide the whole process of clinical development with sponsor’s mindset, while focusing on preventing potential issues. However, if any issue occurs in spite of comprehensive preventive action, the team will track the issues down with best solutions.
GLOBAL TRIAL CONSULTING
- Clinical Development Strategy and Regulatory Pathway Consulting
- CRO Selection
- CRO Communication and Oversight
- Site Qualification Review and Selection
- Project Management: Project Milestones and Timeline
- Study Drug/Device Accountability Consulting
- Unblinded Data & Statistical Review
- Oversight and Management of Clinical Site Monitoring
- Major Ducuments and Deliverables Expert Review